Engineering antibody and T cell receptor fragments : from specificity design to optimization of stability and affinityKevin C. EntzmingerTexas ScholarWorks (Texas Digital Library)December 1, 2014Cited by 0SaveCiteExport RISWatch citationsRelated PapersRapid engineering of SARS-CoV-2 therapeutic antibodies to increase breadth of neutralization including BQ.1.1, CA.3.1, CH.1.1, XBB.1.16, and XBB.1.5|Antibody Therapeutics|2023|11